BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29964204)

  • 1. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
    Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
    Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
    Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
    Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.
    Cruz-Collazo A; Ruiz-Calderon JF; Picon H; Borrero-Garcia LD; Lopez I; Castillo-Pichardo L; Del Mar Maldonado M; Duconge J; Medina JI; Bayro MJ; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
    Mol Cancer Ther; 2021 Dec; 20(12):2420-2432. PubMed ID: 34607932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
    Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
    Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1.
    Chen X; Zhao M; Huang J; Li Y; Wang S; Harrington CA; Qian DZ; Sun XX; Dai MS
    J Cell Biochem; 2018 Jun; 119(6):4945-4956. PubMed ID: 29384218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer.
    Rana PS; Wang W; Markovic V; Szpendyk J; Chan ER; Sossey-Alaoui K
    Cancer Res Commun; 2023 Jan; 3(1):160-174. PubMed ID: 36968231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.
    Zhang W; Yang S; Chen D; Yuwen D; Zhang J; Wei X; Han X; Guan X
    Cell Mol Life Sci; 2022 Jan; 79(1):59. PubMed ID: 34997317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression.
    Kuo WH; Chu PY; Wang CC; Huang PS; Chan SH
    Biol Direct; 2023 Aug; 18(1):44. PubMed ID: 37550720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancer.
    Zhang Y; Zhu X; Qiao X; Gu X; Xue J; Han Y; Sun L; Cui M; Liu C
    J Cell Mol Med; 2020 Aug; 24(16):9125-9134. PubMed ID: 32618099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers.
    Kim DS; Camacho CV; Setlem R; Kim K; Malladi S; Hou TY; Nandu T; Gadad SS; Kraus WL
    Mol Cancer Res; 2022 Nov; 20(11):1623-1635. PubMed ID: 35997635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models.
    Bowers LW; Rossi EL; McDonell SB; Doerstling SS; Khatib SA; Lineberger CG; Albright JE; Tang X; deGraffenried LA; Hursting SD
    Mol Cancer Res; 2018 May; 16(5):869-879. PubMed ID: 29453319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
    Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
    J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
    Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
    Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.
    Xie X; Chauhan GB; Edupuganti R; Kogawa T; Park J; Tacam M; Tan AW; Mughees M; Vidhu F; Liu DD; Taliaferro JM; Pitner MK; Browning LS; Lee JH; Shen Y; Wang J; Ueno NT; Krishnamurthy S; Hortobagyi GN; Tripathy D; Van Laere SJ; Bartholomeusz G; Dalby KN; Bartholomeusz C
    Cancer Res Commun; 2023 Jun; 3(6):1078-1092. PubMed ID: 37377604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S; Yu H; Zhou D; Fan X; Duan Y; Tan Y; Lang M; Shao G
    J Transl Med; 2023 Oct; 21(1):721. PubMed ID: 37838657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional repressor BCL11A promotes breast cancer metastasis.
    Seachrist DD; Hannigan MM; Ingles NN; Webb BM; Weber-Bonk KL; Yu P; Bebek G; Singh S; Sizemore ST; Varadan V; Licatalosi DD; Keri RA
    J Biol Chem; 2020 Aug; 295(33):11707-11719. PubMed ID: 32576660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation.
    Zhong W; Jian Y; Zhang C; Li Y; Yuan Z; Xiong Z; Huang W; Ouyang Y; Chen X; Song L; Liu P; Wang X
    Cancer Lett; 2024 Feb; 582():216516. PubMed ID: 38052369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice.
    Dong J; Kong L; Wang S; Xia M; Zhang Y; Wu J; Yang F; Zuo S; Wei J
    J Exp Clin Cancer Res; 2024 Apr; 43(1):102. PubMed ID: 38566092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
    Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ
    BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
    Liu B; Yang Q; Cheng Y; Liu M; Ji Q; Zhang B; Yang Z; Zhou S; Liu D
    Acta Biomater; 2023 Aug; 166():640-654. PubMed ID: 37236576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.